How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

798 results for

Lidocaine Patch

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

181. Neuropathic pain - drug treatment

management of neuropathic pain in adults in non-specialist settings [ ] . The prescribing information section has been amended in line with the updated NICE guideline referenced above: prescribing information sections for duloxetine and capsaicin cream have been added, and prescribing information sections for drugs no longer recommended by NICE (imipramine, nortriptyline, and lidocaine plasters) have been removed. The evidence section has been rewritten to reflect the changes in the updated NICE (...) as a Schedule 3 controlled drug [ ]. Treatments not recommended in primary care The following drugs are not recommended for the treatment of neuropathic pain in primary care due to a lack of consistent evidence for their effectiveness, evidence of inferiority compared with placebo or other treatments, and/or evidence of a higher risk of adverse effects compared with other drugs [ ]: Carbamazepine (except for trigeminal neuralgia — see the CKS topic on ). Cannabis sativa extract. Capsaicin patch. Imipramine

2019 NICE Clinical Knowledge Summaries

182. Comparison of Synera Patch Versus LMX-4 Cream Versus Placebo Patch for Pain Reduction During Venipuncture in Children

Intervention/treatment Phase Pain Venipuncture Anesthetics, Local Drug: Synera Patch Drug: LMX 4 Cream Drug: Placebo Patch Phase 2 Detailed Description: This study will compare the effectiveness of a patch applied for 30 minutes (Synera-lidocaine 70 mg/tetracaine 70 mg) with the effectiveness of a cream (LMX-4- 4% liposomal lidocaine) and a placebo patch applied for the same length of time in reducing pain due to needle sticks in children. One hundred fifty children and adolescents 5-17 years old admitted (...) of Lidocaine/Tetracaine Patch (SyneraTM), 4% Liposomal Lidocaine Cream (LMX-4) and Placebo for Pain Reduction During Venipuncture in Children Study Start Date : April 2010 Actual Primary Completion Date : June 2011 Actual Study Completion Date : June 2011 Resource links provided by the National Library of Medicine available for: Arms and Interventions Go to Arm Intervention/treatment Experimental: Synera Patch Synera Patch (lidocaine 70 mg/ tetracaine 70 mg) Drug: Synera Patch Synera Patch (lidocaine 70 mg

2010 Clinical Trials

183. Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures

support equipment to consider before the need for rescue occurs). Monitoring devices, such as electrocardiography (ECG) machines, pulse oximeters with size-appropriate probes, end-tidal carbon di- oxide monitors, and defibrillators with size-appropriate patches/ paddles, must have a safety and function check on a regular basis as required by local or state regulation. The use of emergency checklists is recommended, and these should be immediately available at all sedation locations; they can

2016 American Academy of Pediatric Dentistry

184. Use of Local Anesthesia for Pediatric Dental Patients

is effective on surface tissues (up to two to three mm in depth) to reduce painful needle penetration of the oral mucosa. 1,12 Topical anesthetic agents are available in gel, liquid, ointment, patch, and aerosol forms. The U.S. Food and Drug Administration ( FDA) has issued a warning about the use of compounded topical anesthetics and the risk of methemoglobinemia. 13,14 Acquired methemo - globinemia is a serious but rare condition that occurs when the ferrous iron in the hemoglobin molecule is oxidized (...) to the ferric state. This molecule is known as methemoglobin, which is incapable of carrying oxygen. 15 Risk of acquired methemo- globinemia has been associated primarily with two local anesthetics: prilocaine and benzocaine. There is no evidence of other local anesthetics contributing to the etiology of methemo- globinemia. 15 Prilocaine is available topically combined with lidocaine and in an injectable form. Benzocaine, the most commonly used topical anesthetic, is available in concentrations up to 20

2015 American Academy of Pediatric Dentistry

185. Palliative care - oral

assessing a person with oral symptoms in palliative care: Ask about dry mouth, oral pain, halitosis, alteration in taste, excessive salivation, bad breath, difficulty chewing, difficulty speaking, dysphagia, and bleeding. Examine the oral cavity for signs of dehydration, level of oral hygiene, ulceration and vesicles, erythema or white patches, local tumour, bleeding, and infection. The cause of most oral problems can be diagnosed on the basis of clinical features alone, and investigations are rarely (...) -opioid analgesia. For localized pain: Choline salicylate gel — short-lived effect. Excessive use should be avoided because it can lead to ulceration, particularly if the gel is trapped under dentures. Benzydamine spray — relatively short duration of action, and numbness and stinging are sometimes a problem. Lidocaine 5% ointment or 10% spray — duration of action of topical local anaesthetics, such as lidocaine, is relatively short, and these agents will not provide continuous pain relief throughout

2018 NICE Clinical Knowledge Summaries

186. Cardiac arrest - out of hospital care

be continuous at a rate of 100–120 times a minute. As soon as a defibrillator is available, rhythm should be assessed by applying self-adhesive patches to the chest. If ventricular fibrillation (VF) or ventricular tachycardia (VT) is identified, defibrillation should be attempted. One shock of 150 J should be given and CPR immediately resumed. This should be continued for 2 minutes, then paused briefly to check the monitor. If VF/VT persists a second shock of 150 J should be given and CPR immediately (...) ? For information on the assessment of people with suspected cardiac arrest, see the section on . If an is not available, use a . An algorithm for adult advanced life support is available on the Resuscitation Council (UK) website ( ). Defibrillation When should I attempt defibrillation? Continue until a defibrillator is available. As soon as a defibrillator is available, assess the rhythm by applying self-adhesive patches to the chest. Give uninterrupted chest compressions whilst patches are applied

2018 NICE Clinical Knowledge Summaries

187. CRACKCast E003 – Pain Management

(this is limited in acidic environments such as abscesses) What are the two classes? Esters procaine, tetracaine unstable in solution destroyed by plasma enzymes Amides lidocaine, mepivacaine, bupivacaine, etc. destroyed by enzymes in the liver What is the toxic dose of lidocaine and bupivacaine? Toxic doses: Lidocaine: 3-5 mg/kg / with epi: 7 mg/kg (double safe dose) Mepivicaine: 8 mg/kg / with epi: 7 mg/kg (same as safe dose ?no clue why?) Bupivacaine: 1.5 mg/kg / with epi: 3 mg/kg Not recommended in kids (...) therapy is performed with a 20% solution. [7] First, administer a bolus of 1.5 mL/kg over 1 minute. [26, 6, 27, 1] Then convert to an infusion at a rate of 0.25 mL/kg/min for 20 minutes, [6] 30-60 minutes, [26] or until hemodynamic stability is restored. [27] Once the patient attains hemodynamic stability, the infusion should be continued for at least 10 minutes longer. [1] from: List 6 techniques for reducing pain of injection of local anesthetic. buffering 1 ml of bicarbonate to 10 ml of lidocaine

2016 CandiEM

188. True Allergic Responses to Local Anesthetics (LAs) Are Rare, and Safe Alternative Anesthetics Can Be Used for Common Dental Procedures

, and patch testing. The results showed that less than 1% of ADR are truly allergic responses and that no cross-reactions with amides were found, suggesting that safe alternatives may be used for patients who demonstrate adverse type reactions. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Batinac/2013 331 patients that claim to have allergies to “caine” local anesthetics Case Control Study Key results Even (...) though 419 independent adverse drug reactions (ADRs) to local anesthetics were reported in 331 patients who were referred for suspected hypersensitivity, only 3 patients reported a true drug allergy (0.91%). One patient showed a delayed-type reaction (type IV) to bupivacaine and two others showed immediate-type reactions (type I) to Lidocaine. ADRs occur more frequently in women (258, 78%) than men (73, 22%), in patients with a positive history of ADRs to some other drug (146, 44.10%, P Evidence

2016 UTHSCSA Dental School CAT Library

189. Guidelines for the use of local anesthesia in office-based dermatologic surgery Full Text available with Trip Pro

versus lidocaine infiltration to allow closure of skin wounds in children. Emerg Med J . 2005 ; 22 : 507–509 | | | , x 20 Hallen, A., Ljunghall, K., and Wallin, J. Topical anaesthesia with local anaesthetic (lidocaine and prilocaine, EMLA) cream for cautery of genital warts. Genitourin Med . 1987 ; 63 : 316–319 | , x 21 Gupta, A.K. and Sibbald, R.G. Eutectic lidocaine/prilocaine 5% cream and patch may provide satisfactory analgesia for excisional biopsy or curettage with electrosurgery of cutaneous (...) of other commonly used techniques minimize pain? Nerve block/regional anesthesia A. Does nerve block/regional anesthesia represent a clinical benefit over local infiltrative anesthesia for the head and neck, hands, feet, and genitals? B. Does the injection of local anesthesia in the optimal entry points for the head and neck, hands, feet, and genitals pose an increased risk of nerve damage from needle trauma and of toxicity? Tumescent anesthesia A. Is the use of lidocaine in tumescent anesthesia safer

2016 American Academy of Dermatology

194. Effect of Topical Anesthetics on Vaccine

anesthetics assessed in this guideline were 7 lidocaine–prilocaine 5% cream or patch and amethocaine 4% gel. Management of delayed pain after injection was not considered. The 13 studies included, specifically for topical anesthetic as a pain mitigation intervention, investigated immunization pain during intramuscular and subcutaneous injections in 1424 children. Three studies including children 0 to 12 years receiving vaccination in a clinical setting were included in a systematic review that assessed (...) are effective in reducing pain and found no interference with vaccine immunogenicity for measles-mumps-rubella, or for diphtheria, tetanus and, pertussis, polio virus, Hib; and Hep B vaccines. The guideline states that there is no evidence of interference with vaccine immunogenicity with the use of the two topical anesthetics, lidocaine-prilocaine 5% cream or patch and amethocaine 4% gel, studied. This recommendation is based on findings from Randomised Controlled Trials (RCTs). The guideline acknowledged

2015 Peel Health Library

195. Treating carpal tunnel syndrome - Alternative and unproven treatments

for the ointment. Lidocaine patches ( ) This unblinded study randomly allocated 20 patients each to treatment with either an injection of 40mg Depo-Medrol + lidocaine, or application of a lidocaine containing skin patch over the flexor aspect of the wrist for 4 weeks. Outcome assessment was focussed specifically on relief of pain, after 4 weeks of treatment. Both groups improved but the lidocaine patch group seemed to do rather better with 80% of the patch group reporting themselves 'satisfied' or 'very (...) recommended as an initial treatment for CTS the only reliable placebo controlled trial ( ) suggests that they are no more effective than placebo. Furthermore, I have been asking patients for years whether their symptoms respond to over the counter NSAID’s such as Ibuprofen and 62% of 6304 CTS patients said no - so if you have hand pain related to CTS and it is not responding to over the counter medicines that is in fact fairly typical. Local anaesthetic injection Local anaesthetics (lidocaine/procaine


196. Management of chronic pain

oral NSAIDs. 5.2.5 TOPICAL CAPSAICIN Topical capsaicin is available as low dose cream (0.025% or 0.075%) or as a high dose (8%) patch. Few studies of low dose cream were identified but it appears to have no benefit over placebo cream for patients with neuropathic pain. 72 For patients with osteoarthritis three RCTs, ranging from four or twelve weeks in duration, found that low dose capsaicin cream is better than placebo. 73 In studies of patients with postherpetic neuralgia (PHN) and patients (...) with human immunodeficiency virus (HIv ) neuropathy, application of an 8% patch gives significant benefit over placebo. 74 In patients with PHN the NNT was 7 (95% CI 4.6 to 15) for those who were better or very much better at 12 weeks. In patients with HIv neuropathy the NNT was 5.8 (95% CI 3.8 to 12) for those who were better or very much better at 12 weeks. Although of benefit, the cost and specialist application mean that it should be used when other therapies have failed. A Topical capsaicin patches

2013 SIGN

197. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice Full Text available with Trip Pro

–3 antiemetics in addition to propofol based total intravenous anaesthetic (TIVA) has the greatest likelihood of reducing PONV. Examples of antiemetic drugs are serotonin antagonists like ondansetron 4 mg i.v. or dopamine antagonists like droperidol 0.625–1.25 mg i.v. given at the end of surgery or a transdermal patch of scopolamine placed the evening prior to or 2 h before surgery. Dexamethasone 4–5 mg i.v. after induction of anaesthesia has also been shown to be effective, but its

2015 ERAS Society

198. Pharmacological Management of Cancer Pain in Adults

with a history of addiction 107 2.4. Non-Opioid Pharmacological Management 111 2.4.1 Paracetamol 111 2.4.2 Non-steroidal anti-inflammatory drugs (NSAIDs) 113 2.4.3 Anti-depressants and anti-epileptics 116 2.4.4 Bisphosphonates 119 2.4.5 Corticosteroids 122 2.4.6 Ketamine 124 2.4.7 Lidocaine 127 2.4.8 Capsaicin 130 2.5. The use of opioids in patients with renal impairment 132 2.5.1 Renal impairment: classification 132 2.5.2 Renal impairment in cancer 132 2.5.3 Guidance for opioid prescribing in renal (...) . • Determining the role for ketamine in a cancer pain setting. • Determining the role of parenteral lidocaine in the management of opioid refractory cancer pain. • Determining the role of topical capsaicin in the management of neuropathic pain in a cancer setting. • Further evaluation of the use of opioids in a renal and liver failure setting. 1.12 Resource implications Estimates indicate that 50%-90% of cancer patients experience pain at some stage (24). The costs of unrelieved pain are potentially very

2015 National Clinical Guidelines (Ireland)

199. Polymodal Mechanism for TWIK-Related K+ Channel Inhibition by Local Anesthetic. (Abstract)

characterized indirect PA-mediated inhibition of TREK-1 by monitoring lipid production in live whole cells using a fluorescent PLD2 product release assay and ion channel current using live whole-cell patch-clamp electrophysiology. We monitored anesthetic-induced nanoscale translocation of PLD2 to TREK-1 channels with super-resolution direct stochastic reconstruction microscopy (dSTORM).We find local anesthetics tetracaine, lidocaine, and bupivacaine directly bind to and inhibit PLD2 enzymatic activity (...) . The lack of PLD2 activity indirectly inhibited TREK-1 currents. Select local anesthetics also partially blocked the open pore of TREK-1 through direct binding. The amount of pore block was variable with tetracaine greater than bupivacaine and lidocaine exhibiting a minor effect. Local anesthetics also disrupt lipid rafts, a mechanism that would normally activate PLD2 were it not for their direct inhibition of enzyme catalysis.We propose a mechanism of TREK-1 inhibition comprised of (1) primarily

2019 Anesthesia and Analgesia

200. Cancer Pain (PDQ®): Health Professional Version

. [ ] Lee JS, Hu HM, Edelman AL, et al.: New Persistent Opioid Use Among Patients With Cancer After Curative-Intent Surgery. J Clin Oncol 35 (36): 4042-4049, 2017. [ ] [ ] Sauerland C, Engelking C, Wickham R, et al.: Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum 33 (6): 1134-41, 2006. [ ] Pucino F, Danielson BD, Carlson JD, et al.: Patient tolerance to intravenous potassium chloride with and without lidocaine. Drug Intell Clin Pharm 22 (9

2017 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>